Immune gene expression in head and neck squamous cell carcinoma patients
Charlotte Lecerf(Institut Curie), Christophe Le Tourneau(Inserm)
Cited by 64
Related Papers
Dose Escalation Methods in Phase I Cancer Clinical Trials
|JNCI Journal of the National Cancer Institute|2009|856
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
|Journal for ImmunoTherapy of Cancer|2018|165